지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.2
- 수록면
- 66 - 74 (9page)
이용수
초록· 키워드
오류제보하기
Backgrounds/Aims: Various factors have been reported as prognostic factors of non-functional pancreatic neuroendocrine tumors (NF-pNETs). There remains some controversy as to the factors which might actually serve to successfully prognosticate future manifestation and diagnosis of NF-pNETs. As well, consensus regarding management strategy has never been achieved. The aim of this study is to further investigate potential prognostic factors using a large single-center cohort to help determine the management strategy of NF-pNETs. Methods: During the time period 1995 through 2013, 166 patients with NF-pNETs who underwent surgery in Samsung Medical Center were entered in a prospective database, and those factors thought to represent predictors of prognosis were tested in uni- and multivariate models. Results: The median follow-up time was 46.5 months; there was a maximum follow-up period of 217 months. The five-year overall survival and disease-free survival rates were 88.5% and 77.0%, respectively. The 2010 WHO classification was found to be the only prognostic factor which affects overall survival and disease-free survival in multivariate analysis. Also, pathologic tumor size and preoperative image tumor size correlated strongly with the WHO grades (p＜0.001, and p＜0.001). Conclusions: Our study demonstrates that 2010 WHO classification represents a valuable prognostic factor of NF-pNETs and tumor size on preoperative image correlated with WHO grade. In view of the foregoing, the preoperative image size is thought to represent a reasonable reference with regard to determination and development of treatment strategy of NF-pNETs.
목차
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
췌장신경내분비종양의 진단과 치료에 대한 초음파 내시경의 활용
대한췌담도학회지
2021 .01
-
Diagnosis of Pancreatic Neuroendocrine Tumors
Clinical Endoscopy
2017 .01
-
The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine Tumors
Clinical Endoscopy
2020 .01
-
Non-surgical treatment modalities of PNETs. What’s new?
대한외과학회 학술대회 초록집
2015 .11
-
Limitation of Current Size-oriented Treatment Indications for PNET
대한외과학회 학술대회 초록집
2022 .11
-
Advances in the Management of Unresectable or Metastatic Pancreatic Neuroendocrine Tumors: Chemotherapy, Targeted Therapy, Hormonal Treatment, and Future Directions
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Is It Justified that Differentiation Classify G3 PNET?
대한외과학회 학술대회 초록집
2018 .11
-
췌장신경내분비종양의 내과적 치료
대한췌담도학회지
2021 .01
-
How should we deal with small PNETs : is 2cm a golden reference?
대한외과학회 학술대회 초록집
2015 .11
-
간전이가 있는 췌장신경내분비종양의 인터벤션 치료
대한췌담도학회지
2021 .01
-
Pediatric Ewing’s Sarcoma/Primitive Neuroectodermal Tumor (ES/PNET) Developed in the Small Intestine: A Case Report
Clinical Pediatric Hematology-Oncology
2017 .01
-
The role of surgical management in locally advanced and extensive metastatic PNETs
대한외과학회 학술대회 초록집
2015 .11
-
Reliability of PNET staging : AJCC vs. WHO
대한외과학회 학술대회 초록집
2015 .11
-
Therapy of Pancreatic Neuroendocrine Tumors: Fine Needle Intervention including Ethanol and Radiofrequency Ablation
Clinical Endoscopy
2017 .01
-
진행성 췌장 신경내분비종양의 최적 치료
대한췌담도학회지
2016 .01
-
Treatment Strategy of Pancreatic Neuroendocrine Tumors Suggested Based on Korean Multicenter Prognostic Factor Analysis
대한외과학회 학술대회 초록집
2019 .10
-
Comparison of the Prognostic Factors according to Tumor Size in Small Breast Cancer
대한외과학회 학술대회 초록집
2022 .05
-
Robotic enucleation of a pancreatic uncinate neuroendocrine tumor – a unique parenchyma-saving strategy for uncinate tumors
Annals of Hepato-Biliary-Pancreatic Surgery
2020 .02
-
Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database
Cancer Research and Treatment
2019 .01
-
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
Journal of Gastric Cancer
2017 .06
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2018-514-001759975